Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05502198
What this trial is testing

Relevance of Sarcopenia in Advanced Liver Disease

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSarcopenia+1 more
Linkoeping University 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506
What this trial is testing

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerHER-2 Protein Overexpression
Fudan University 20
Not applicableStudy completedNCT02662816
What this trial is testing

Non-invasive Quantification of Muscle and Liver Glutathione GSH-MRS

Who this might be right for
Assay MuscleLiver Glutathione in Healthy Human
University Hospital, Clermont-Ferrand 6
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Not applicableStudy completedNCT06768346
What this trial is testing

Hyperthermic Intra-Vesical Chemotherapy

Who this might be right for
Bladder Cancer
Queen Mary University of London 259
Not applicableWithdrawnNCT03575507
What this trial is testing

Non-invasive Improvement of Buttocks With Magnetic Device

Who this might be right for
Muscle Tightness
BTL Industries Ltd.
Large-scale testing (Phase 3)Active Not RecruitingNCT05714202
What this trial is testing

TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

Who this might be right for
Bladder Cancer
Janssen Research & Development, LLC 1,135
Not applicableStudy completedNCT07642102
What this trial is testing

Evaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Transurethral Resection of Bladder Tumor
Ain Shams University 70
Not applicableEnded earlyNCT04412070
What this trial is testing

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

Who this might be right for
Bladder Cancer
Hopital Foch 20
Not applicableStudy completedNCT06126796
What this trial is testing

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Mayo Clinic 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823
What this trial is testing

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc. 20
Early research (Phase 1)Looking for participantsNCT07483970
What this trial is testing

A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.

Who this might be right for
High Risk Non-muscle Invasive Bladder Cancer
Jecho Biopharmaceuticals Co., Ltd. 18
Not applicableUnknownNCT02716961
What this trial is testing

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerGemcitabine and Cisplatin ChemotherapyEpirubicin Instillation+2 more
The First Affiliated Hospital with Nanjing Medical University 208
Large-scale testing (Phase 3)Looking for participantsNCT07804056
What this trial is testing

Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer (NMIBC)
Hamlet Pharma AB 194
Early research (Phase 1)Study completedNCT01498172
What this trial is testing

BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Bladder Cancer
Patrice Jichlinski 23
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06732531
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerNon Muscle Invasive
Zhuhai Beihai Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800507
What this trial is testing

Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer

Who this might be right for
NMIBC
Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777848
What this trial is testing

Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 114
Early research (Phase 1)Study completedNCT05085990
What this trial is testing

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 10
Next Page